Supporting treatment decision-making in psychosis: The DEC:IDES trial
Research type
Research Study
Full title
Decision-making Capacity Intervention Development & Evaluation in Schizophrenia-spectrum disorder: The DEC:IDES trial
IRAS ID
263575
Contact name
Paul Hutton
Contact email
Sponsor organisation
Edinburgh Napier University
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 7 months, 29 days
Research summary
Psychosis can sometimes affect a person’s ability to make their own decisions about treatment. This means other people, including doctors, may make these decisions instead. The aim of this study is to complete three small ‘feasibility’ trials of psychological therapies to help people with psychosis make their own decisions about treatment. This will help us design larger trials. Sixty participants with psychosis and impaired treatment decision-making ability will be invited to enter one of these small trials (20 participants per trial), based on what might affect their decision-making (i.e., self-esteem, self-stigma or gathering enough information to make decisions). In each trial, participants will have a 50% chance of receiving either 6 weekly sessions of therapy for their difficulties, or 6 weekly sessions of further assessment alone. We will assess their ability to make treatment decisions before and after these sessions, and 4-5 months later. However the main outcomes we are interested in at this stage are the number of people who agree to take part and enter these trials, and the number of people who choose to stay in them until they are finished.
REC name
Scotland A: Adults with Incapacity only
REC reference
19/SS/0069
Date of REC Opinion
28 Jun 2019
REC opinion
Favourable Opinion